Related Experiment Video
Updated: May 28, 2025

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
Published on: November 1, 2024
Racial Differences in Disease Characteristics of Pediatric Hidradenitis Suppurativa
Toluwalashe Onamusi1,2, Jennifer Murphy3, Sonal D Shah1,2
1Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Insights
Racial differences in pediatric hidradenitis suppurativa (HS) presentation and outcomes require further study. While biologic treatment use varied slightly, understanding these disparities is crucial for equitable care in children with HS.
Area of Science:
- Dermatology
- Pediatrics
- Health Equity
Background:
- Pediatric hidradenitis suppurativa (HS) is increasingly recognized.
- Understanding racial disparities in HS presentation, severity, and outcomes is vital for equitable care.
- This study investigates racial differences in pediatric HS at a single institution.
Purpose of the Study:
- To analyze potential racial differences in pediatric hidradenitis suppurativa.
- To compare presentation, severity, and treatment outcomes between racial groups.
- To inform individualized and equitable care strategies for pediatric HS patients.
Main Methods:
- Retrospective analysis of 70 pediatric patients with HS.
- Data collected from a single academic institution.
- Comparison of treatment patterns between non-Hispanic Black (NHB) and non-Hispanic White (NHW) patients.
Main Results:
- No statistically significant difference in biologic treatment use between NHB and NHW pediatric HS patients.
- NHW patients received biologic therapy more frequently (17.4%) than NHB patients (12.8%).
- Observed racial differences suggest underlying factors contributing to disease heterogeneity.
Conclusions:
- Racial differences in pediatric HS warrant further investigation.
- Understanding disease heterogeneity and treatment response is key to optimizing care.
- Further research is needed to address disparities and improve outcomes for all children with HS.
Abstract:
Understanding the potential racial differences in presentation, severity, and outcomes of pediatric hidradenitis suppurativa (HS) can help deliver equitable and individualized care, especially as this condition is increasingly being acknowledged in this population. We conducted a single-center retrospective analysis of 70 pediatric patients diagnosed with HS who were seen at our institution. There was no statistically significant difference in biologic treatments between non-Hispanic Black (NHB) patients when compared to non-Hispanic White (NHW) patients, although NHW patients overall received biologic therapy more frequently (17.4%) than NHB patients (12.8%). The observed racial differences in pediatric HS highlight the need for further investigation of possible underlying factors contributing to disease heterogeneity and treatment response to optimize the care provided and patient outcomes.
More Related Videos
Related Concept Videos
Pedigree Analysis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Comparing the Survival Analysis of Two or More Groups
Pleiotropy
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Sex-linked Disorders

